LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis C$10.32 -0.44 (-4.05%) As of 08:35 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsNews and Trends About Ondine Biomedical Stock (LON:OBI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Ondine Biomedical alerts:Sign Up Key Stats Today's RangeC$9.60▼C$10.3250-Day RangeC$10.25▼C$14.0052-Week RangeC$7.50▼C$15.50Volume1.35 million shsAverage Volume583,694 shsMarket CapitalizationC$5.36 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada. Read More Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OBI Stock News HeadlinesOndine wins five Ontario hospitals for Steriwave infection treatmentSeptember 23 at 4:27 AM | finance.yahoo.comOndine Biomedical CTO: LANTERN results 'change the entire nature of the company'September 16, 2026 | uk.finance.yahoo.comIran War TRUTH: What Two Congressmen Led Me ToTwo private meetings with U.S. Congressmen on March 2nd, three days after the first missiles fell, sent one analyst down an unexpected research trail. The investigation uncovered a coordinated operation, a shadow group running it, and one company sitting at the center of it all.September 24 at 1:00 AM | Behind the Markets (Ad)Ondine Biomedical gains 5% as LANTERN clears phase III hurdleSeptember 10, 2026 | finance.yahoo.comIncanthera, Ondine, Rainbow Rare Earths, Tertiary Minerals, Strategic Minerals, Futura MedicalSeptember 7, 2026 | finance.yahoo.comOndine Biomedical share price rallies following 40% drop in surgical infectionsSeptember 1, 2026 | uk.finance.yahoo.comONDINE BIOMEDICAL INC. COM SHS (OBI.L) H2 FY2025 earnings call transcriptAugust 27, 2026 | finance.yahoo.comOndine Biomedical Inc.July 8, 2026 | marketwatch.comSee More Headlines OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed this year? Ondine Biomedical's stock was trading at C$8.75 at the beginning of the year. Since then, OBI stock has increased by 22.9% and is now trading at C$10.75. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Ondine Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB). Industry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:OBI Previous SymbolLON:OBI CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($6.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$424.66 thousand Net Margins-1,117.06% Pretax MarginN/A Return on Equity-1,411.54% Return on Assets-159.71% Debt Debt-to-Equity Ratio11.85 Current Ratio1.23 Quick Ratio8.26 Sales & Book Value Annual SalesC$2.65 million Price / Sales2,110.80 Cash FlowC$5.40 per share Price / Cash Flow1.99 Book ValueC$0.01 per share Price / Book1,244.98Miscellaneous Outstanding Shares519,551,000Free FloatN/AMarket CapC$5.59 billion OptionableNot Optionable Beta0.30 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (LON:OBI) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
